Table 1.
Characteristics at ICD implant of the 118 patients analyzed regarding KCCQ-12
| n (%) | |
|---|---|
| Patients | 118 |
| Mean age at implant (years) | 65.0 ± 10.4 |
| Mean age at KCCQ (years) | 70.9 ± 9.8 |
| Females | 20 (16.9) |
| Ischemic etiology | 69 (58.5) |
| Device type | |
| ICD-VR | 16 (13.6) |
| ICD-DR | 45 (38.1) |
| CRT-D | 57 (48.3) |
| Hypertension | 54 (45.8) |
| Diabetes mellitus | 27 (22.9) |
| Renal failure* | 16 (13.6) |
| Atrial fibrillation | 35 (29.7) |
| Beta-blockers | 106 (89.8) |
| ACE-i/ARB | 111 (94.1) |
| MRA | 75 (63.6) |
Data presented as frequencies (percentage in parenthesis)
ACE-i angiotensin converting enzyme inhibitor, ARB angiotensin receptor blockers, CRT-D cardiac resynchronization therapy defibrillator, ICD-DR dual lead implantable cardioverter defibrillator, ICD-VR single lead implantable cardioverter defibrillator, KCCQ-12 12-item Kansas City Cardiomyopathy Questionnaire, MRA mineralcorticoid receptor antagonists
*Defined as S-Creatinine ≥ 130 μmol/L